PHARMACEUTICAL IP

Alice Walford joins Evolve

  • Sector: Patent law
Alice Walford Patent Attorney

We are delighted to welcome Alice Walford to the Evolve team.

Alice joins us with over 15 years of combined private practice and in-house experience in the life sciences sector. Alice brings a wealth of experience, including time at Novartis, Gyroscope Therapeutics and Abzena, working on gene therapies, small molecule and antibody assets. Her specialist knowledge further strengthens our ability to provide strategic and forward-thinking advice, as we continue to support innovation in the pharmaceutical industry.

Welcome aboard Alice!

Related insights...

Evolve’s Claudia Greaves earns CIPA Advanced Patent Paralegal Qualification

We are delighted to announce that Evolve’s Claudia Greaves, has recently passed the CIPA Advanced Patent Paralegal Course (APPC). Building on her six years of patent law experience, Claudia completed intensive modules that deepen her expertise in critical areas of IP management: The Patent Cooperation Treaty (PCT): Gaining in-depth understanding of both the International Phase…

Evolve Intellectual Property celebrates 4 years!

Last month, Evolve celebrated its 4-year anniversary in style with a sparkling wine and canapés reception in Cambridge. Thank you to everyone who attended and for our clients’ continued trust and support. We look forward to many more years of helping our clients in their mission to deliver innovative medicines to market and bring hope…

Launch of Evolve Webinars!

A series of live webinars on IP strategy for pharma & biotech professionals.

Evolve’s Steven Gurney recognised in IAM 1000 2025

We are delighted to announce that Evolve’s founder Steven Gurney has once again be recognised in the IAM patent 1000.

Event report: C5 Pharma & Biotech Patent Litigation in Europe (Day 1), Plausibility, UPC and antibody IP strategy

Navigating European pharma and biotech patent litigation is more complex than ever, with ongoing debates on plausibility, UPC intricacies, claim interpretation, and divergent strategies for antibody inventions.

Rose Hughes joins Evolve

Evolve Intellectual Property is pleased to welcome Dr. Rose Hughes as our new Patent Attorney.

Evolve joins the ranks of the Legal 500

We are delighted to announce that Evolve has joined the ranks of the Legal 500 Intellectual Property firms. The Legal 500 is one of the UK’s leading legal directories, known for its rigorous research methodology and independent analysis of the legal market. As a small boutique IP firm, we are particularly proud of this achievement. …
All Insights